Cost-of-illness of patients with systemic sclerosis in a tertiary care centre

Minier, Tünde; Péntek, Márta; Brodszky, Valentin; Ecseki, Adrienn; Kárpáti, Krisztián; Polgá r, Anna; Czirják, László; Gulács, László
October 2010
Rheumatology;Oct2010, Vol. 49 Issue 10, p1920
Academic Journal
Objective. The aim of our study was to assess the costs of SSc and to analyse cost drivers.


Related Articles

  • Telehealth Consultations in Rheumatology: Cost-Effectiveness and User Satisfaction. Davis, Paul; Howard, Ray; Brockway, Pam // Journal of Telemedicine & Telecare;Oct2011 Supplement, Vol. 7 Issue 1, p10 

    We conducted a feasibility study to assess user satisfaction with and the cost-effectiveness of a rheumatology telehealth clinic in northern Alberta. Six telehealth clinics were organized between a rural health centre and the specialist rheumatology centre, which was about a 4h drive away....

  • Costs of systemic scleroderma "substantial" in Canada.  // PharmacoEconomics & Outcomes News;3/21/2009, Issue 574, p4 

    The article reveals that the costs of systemic scleroderma are substantial in Canada according to a cost-effectiveness study. The study measured annualised averages of direct medical costs as well as indirect costs incurred by 457 patients with the condition. The average total annual cost per...

  • Beyond the shame and blame game. Reynolds, Sherry // H&HN: Hospitals & Health Networks;Oct2012, Vol. 86 Issue 10, p14 

    A letter to the editor is offered in response to the cover story "Health Care's Costliest 1%" by Haydn Bush from the September 2012 issue.

  • Paid not to refer? Levinson, Wendy; Levinson, W // JGIM: Journal of General Internal Medicine;Mar2001, Vol. 16 Issue 3, p209 

    Focuses on the influence of the financial incentives of physicians on trust between doctors and patients. Importance of discussing financial arrangements with patients; Use of communication skills training programs; Factors influencing the decision-making of doctors.

  • Physician incentives and disclosure of payment methods to patients. Kao, Audiey C.; Zaslavsky, Alan M.; Green, Diane C.; Koplan, Jeffrey P.; Cleary, Paul D.; Kao, A C; Zaslavsky, A M; Green, D C; Koplan, J P; Cleary, P D // JGIM: Journal of General Internal Medicine;Mar2001, Vol. 16 Issue 3, p181 

    Objective: There is increasing public discussion of the value of disclosing how physicians are paid. However, little is known about patients' awareness of and interest in physician payment information or its potential impact on patients' evaluation of their care.Design:...

  • Money talks, patients walk? Ubel, Peter A.; Ubel, P A // JGIM: Journal of General Internal Medicine;Mar2001, Vol. 16 Issue 3, p204 

    Editorial. Comments on the problems in informing patients about physician reimbursement. Reluctance in discussing health care finances; Impact of the physician payment information on patients; Approach to the disclosure of financial issues to patients.

  • The price of noncompliance.  // Family Practice Management;Feb2002, Vol. 9 Issue 2, p23 

    Reports the influence of increased pharmaceutical costs and co-payments in drug noncompliance in the United States.

  • $754 BILLION. Bjerklie, David // Time;8/1/2005, Vol. 166 Issue 5, p66 

    Focuses on the amount of money that was charged patients for hospital stays in the United States in 2003. Cost of other medical conditions and the number of patients that suffered from them.

  • Adherence is a pricey problem. M. A. // Medical Marketing & Media;Jun2010, Vol. 45 Issue 6, p11 

    The article reports on the claims of an Express Scripts study that the medical costs of patient non-adherence to therapy costs 106 billion dollar each year in the U.S.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics